Underwrite.ai applies AI-first models influenced by genomics and particle physics to deliver rapid, nonlinear credit risk assessments that significantly improve predictive accuracy—with full explainability, zero up-front costs, and compliance baked in.
Grannus is pioneering a breakthrough generation of Hsp90 inhibitors that are highly selective for the β‑isoform—delivering potent anti‑tumor efficacy, clean safety profiles, and strong tumor‑targeted biodistribution as they advance toward clinical milestones with robust IP protection.
We developed a flexible, component-driven design system that streamlines MediaSilo’s suite of creative tools—ensuring visual consistency, faster product development, and a cohesive user experience across multiple brands and platforms.